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Knowledge of the regional tissue distribution of T cell subsets is a prerequisite for understanding protective
immunity and the pathophysiology of T cell-mediated diseases. In this issue of Immunity, Sathaliyawala et al.
(2012) present a comprehensive human tissue T cell analysis.In the 16th century, modern anatomy
became the basic science with which
to study the human body’s function
(O’Malley, 1964). Since then it has funda-
mentally contributed to our achievements
in clinical—especially operative—medi-
cine, where it has made surgeries of the
highest complexity (e.g., organ transplan-
tations) possible today. The introduction
of microscopic anatomy in the 1800s
allowed a deeper understanding of organ
and tissue function, but histologic stain-
ings also had their immanent restric-
tions: surface molecule combinations
defining an individual cell’s ontogeny
and purpose are difficult to determine in
(fixed) tissue sections. For this reason
the role of ‘‘small lymphocytes’’ remained
elusive (Gowans, 1996) for decades,
until monoclonal antibodies and flow
cytometry enabled the discrimination of
more and more lymphocyte subsets on
the single-cell level and helped to deci-
pher their function for adaptive immune
responses. Today state-of-the-art multi-
color flow cytometry allows reliable
discrimination of more than a dozen
subset markers in one single sample,
but this usually requires fresh ex-vivo-
isolated leukocytes. Consequently, flow-
cytometric analyses in humans have
been mainly restricted to easily attainable
sources for living lymphocytes such as
peripheral blood, whereas systematic
lymphoid or mucosal tissue examina-
tions (except for examinations of occa-
sional surgical specimens) have not
been possible.
In mice, however, those systematic
ex vivo organ-tissue analyses are both
technically and ethically feasible, and
recent studies on T cell memory have10 Immunity 38, January 24, 2013 ª2013 Elsunderlined their importance. For ex-
ample, resident memory T cell subsets
that might potentially be important medi-
ators of local immunity protecting against
reinfections of formerly encountered
pathogens (as summarized in Masopust
and Picker, 2012) have been identified.
Because the confirmation of comparable
distribution patterns of T cell subsets
in humans is necessary (Davis, 2008)
before potential implications for, as an
example, vaccine-induced T cell re-
sponses can be fully assessed, compre-
hensive human analyses of tissue distri-
bution of memory T cell subsets are
urgently needed.
Sathaliyawala et al. (2012) have now
addressed this issue by collecting lym-
phoid and mucosal tissues from 24
brain-dead organ donors. They received
lung, small intestine, and colon tissue
together with their respective draining
lymph nodes in addition to blood, inguinal
lymph nodes, and splenic tissue at the
time of donor organ explantation. Those
exceptional conditions allowed ‘‘ex vivo’’
flow-cytometry analyses with the highest
cell vitality of the isolated lymphocyte
samples, enabling the researchers to
perform even functional analyses. All
donors were younger than 60 years, free
from chronic and immunological dis-
eases, and had succumbed mostly to
traumatic causes. Those characteristics
allowed a unique snapshot of a presum-
ably physiological T cell distribution.
Intriguingly, a general observation is
that despite individual backgrounds and
presumed variable infection or vaccina-
tion histories, distributions of common
tissue-specific T cell subsets could be
identified. Specifically, the early activa-evier Inc.tion marker CD69 is highly expressed
on memory T cells from mucosal and
lymphoid tissues but could only be
detected (with individual exceptions) on
a minority of memory T cells in the blood
compartment. Sathaliyawala et al. inter-
pret this CD69 expression as a marker
for resident memory T cells and thus as
support for earlier observations describ-
ing CD69-expressing resident memory
T cells in non-lymphoid tissues of mice
(Jiang et al., 2012). However, CD69-
expressing resident memory T cells are
also found in secondary lymphoid organs
in this study, contrasting with current
analyses in mice.
With the help of well-established
markers (CD45RA, CD45RO, and CCR7)
for T cell subsets, the authors dis-
criminate between naive, central memory
(Tcm), effector memory (Tem), and
CD45RA-re-expressing memory (Temra)
T cells. In particular, the physiological
role of Temra cells, which have been
found to display an effector-like pheno-
type, is not yet completely understood.
They are predominantly found among
T cells directed against persisting viruses
such as Cytomegalovirus (CMV) and
accumulate with age (Buchholz et al.,
2011). In the current study, Temra cells
are nearly exclusively found within CD8+,
but not CD4+, T cell subsets. Because
detection of previously described CD4+
CD45RA+ memory T cells correlates with
CMV seropositivity and advanced age
(Henson et al., 2012), this discrepancy
could be due to the overall young age of
the organ donors. Nevertheless, incorpo-
ration of the routinely available results
of virus serology of organ donors into
the individual data sets might enable
Figure 1. Woodcuts from De Humani Corporis Fabrica libri septem by Andreas Vesalius
(Left) Initial from the Fabrica‘s preface, which Vesalius dedicated to the emperor Charles V. Vesalius. In
it, Vesalius states that he was trained during his medical studies only in a couple of animal preparations
before he started to conduct human dissections himself ("ut ipse in brutorum aliquot sectionibus ... ver-
satus ... sectionem, solito absolutius ... adductus publice` administrarem") and that by those experiences
he had come to the conclusion that Galen had never dissected a human being for his classical anatomic
studies ("nobis modo` ex renata dissectionis arte ... constet ... nunquam ipsum [Galen] resecuisse corpus
humanum).
(Right) Detail from the title page: Vesalius conducts a public human dissection.
Images are from Vesalius, A. (1543). De humani corporis fabrica libri septem. (Basileae: Ex officina Joan-
nis Oporini). Photographs were kindly provided by the University Library of Munich (Ludwig-Maximilians-
Universitaet), W 2 Med. 580.
Immunity
Previewscorrelation of phenotypic findings with
highly prevalent latent herpes virus
infections.
In comparison to CD4+ Tcm cells, CD8+
Tcm cells are found throughout all tested
lymphoid and mucosal tissues at low
frequencies. Even though the reason for
this difference remains to be determined,
the ubiquitous paucity of CD8+ Tcm
cells actually fits well into a concept of
low-numbered but highly proliferative
stem-cell-like memory T cells that endure
self-renewal and long-time survival (Neu-
enhahn and Busch, 2009). In order to
solidify this concept, however, it could
be attractive to extend future analyses
to bone marrow (Mazo et al., 2005) and
other potential organ niches for CD8+
Tcm cells.
In summary, the comprehensive organ-
specific human lymphocyte phenotyping
by Sathaliyawala et al. will be a valuable
resource for human T cell analyses.
Thus, the current data should be seen
more as a starting point for further immu-
nological in-depth analyses than as a
completed human T cell evaluation. Stain-
ing protocols can be adapted and opti-
mized (parameters were already changed
during the current study), and more
specific target populations (e.g., regula-
tory or antigen-specific T cells) shouldbe addressed in the future. The imme-
diate, gentle sample preparation is in
this context an invaluable advantage
because subset-defining functional multi-
parameter stainings can be optimally
performed. Furthermore, immunization
histories and results from infection
serology should be correlated. Finally,
additional tissues (e.g., thymus and bone
marrow) could be included, although
some organ-tissue recuperations might
be incompatible with prioritized transplant
use (liver) or irreconcilable with the integ-
rity of the corpse’s exterior (skin). With
those restrictions in mind, a (nearly)
whole-body human T cell anatomy could
become reality.
Because such analyses performed as
soon as possible postmortem could in
principal be extended to other immuno-
logical and nonimmunological cytometric
analyses, these manifold and highly valu-
able scientific examinations will probably
need to be performed at more than one
scientific center. This raises the question
of whether the approach of ‘‘ex vivo’’
tissue analyses from brain-dead organ
donors could also become a more widely
accepted strategy in other institutions or
countries. The ethical implications need
to be discussed by the respective
national medical societies and ethicalImmunity 3committees, but an informed consent
by the organ donor seems mandatory.
In most western countries, whole-body
donation for medical research and
education is legally and structurally well
established and ethically accepted,
but it might be difficult to reconcile
scientific interest in organ-donor tissues
with national organ-procurement poli-
cies. In Europe, the responsible institu-
tions often refrain from asking organ
donors for general acceptance of post-
mortem research analyses in order to
minimize the hurdle for donation in
the context of today’s dramatic organ
shortage. Scientific study of donor
tissues, in particular immunological anal-
ysis, could greatly increase the overall
success of clinical therapies, including
organ transplantation. If these benefits
become clear to potential organ donors
and responsible transplant authorities,
acceptance of such scientific analysis
could pave the way for a new era of
understanding.
Nearly 500 years ago, Andreas Vesa-
lius (1514–1564), physician and father
of modern anatomy, found himself,
admittedly in a more general way, in
a comparable situation. Vesalius took
advantage of the Renaissance Society’s
renewed acceptance of human dissec-
tions and, being a gifted anatomic
dissector himself, discovered during a
series of self-performed human dissec-
tions various misconceptions in Galen’s
medical doctrine, which was universally
accepted at that time. Galen had per-
formed most of his anatomic studies in
animals, and a couple of faulty conclu-
sions had been accepted because
nobody questioned his authority. Vesa-
lius summarized his findings in the
revolutionary book on human anatomy,
De Humani Corporis Fabrica (Figure 1),
and paved the way for henceforth
regular human dissections in anatomic
research and medical education. The
Vesalian conclusion that only post-
mortem examinations in humans could
eventually provide a complete picture
of the human body’s functions can be
seen as a strong argument for the need
for more human postmortem studies
such as that by Sathaliyawala et al.
In that sense, the data set presented
by Sathaliyawala et al. will become
an important resource for clinical
immunology.8, January 24, 2013 ª2013 Elsevier Inc. 11
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